Contract manufacturing news in brief
Robinson Pharma, Vybion, Prosensa, Diosynth Biotechnology, ImmunoGen and Novogen have all recently announced new contract manufacturing deals.
Robinson Pharma, Vybion, Prosensa, Diosynth Biotechnology, ImmunoGen and Novogen have all recently announced new contract manufacturing deals.
It might look like a simple breath freshener dissolving mouth-strip but the John Hopkins University innovation is just steps away from cutting costs and saving thousands of lives from the deadly rotavirus.
A French firm developing an innovative gene delivery tool has received a cash boost of €80,000 to ramp up good manufacturing processes for its synthetic delivery molecule.
A transdermal patch for needle-free delivery of insulin and a diagnostic test for rapid detection of meningococcal disease are among the products under development by two new Australian companies set up to commercialise the research outcomes of...
The market's first nebulized form of formoterol fumarate for chronic obstructive pulmonary disease (COPD) has been given the go ahead by the US Food and Drug Administration (FDA).
Lower than expected yields of varicella zoster virus (VZV) have forced Merck & Co to run down US supplies of ProQuad, its all-in-one children's vaccine for measles, mumps, rubella (German measles) and varicella (chickenpox).
Larger, high-value, reusable containers will drive demand for rigid packaging by 3.5 per cent each year, reaching $6.6bn in 2011, according to a new report.